Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Acquisitions & Divestments (2016)

Cytosorbents (CTSO) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $249000.0 as the latest value for Q3 2016.

  • For the quarter ending Q3 2016, Change in Acquisitions & Divestments changed N/A year-over-year to $249000.0, compared with a TTM value of $2.2 million through Dec 2017, changed 0.0%, and an annual FY2016 reading of $2.2 million, down 59.64% over the prior year.
  • Change in Acquisitions & Divestments was $249000.0 for Q3 2016 at Cytosorbents, down from $1.9 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.9 million in Q2 2016 and bottomed at $249000.0 in Q3 2016.
  • Average Change in Acquisitions & Divestments over 4 years is $619379.6, with a median of $393607.0 recorded in 2012.
  • Peak annual rise in Change in Acquisitions & Divestments hit 0.0% in 2012, while the deepest fall reached 0.0% in 2012.
  • Year by year, Change in Acquisitions & Divestments stood at $393607.0 in 2012, then changed by 0.0% to $393607.0 in 2013, then skyrocketed by 216.7% to $1.2 million in 2015, then tumbled by 80.02% to $249000.0 in 2016.
  • Business Quant data shows Change in Acquisitions & Divestments for CTSO at $249000.0 in Q3 2016, $1.9 million in Q2 2016, and $1.2 million in Q1 2015.